Balversa 4 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DB25FHR42
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,623.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for BALVERSA 4 mg tablets (28-count packaging) valued at $25,623.22. The award, issued on June 27, 2025, with an ultimate completion date of July 21, 2025, represents a competitively awarded, firm fixed-price contract with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
The contract supports the Defense Logistics Agency's Medical Supply Chain operations, which provide pharmaceutical products to military healthcare systems and other federal medical procurement needs. AmerisourceBergen's substantial IDC vehicle enables the company to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. This specific delivery order for BALVERSA, a cancer treatment medication, exemplifies the company's role as a critical vendor in federal medical procurement and its capability to fulfill specialized pharmaceutical requirements across the defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FHR42?
SPE2DB25FHR42 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 27, 2025.
How much is contract SPE2DB25FHR42 worth?
The government has obligated $25,623 on SPE2DB25FHR42.
Is contract SPE2DB25FHR42 an order under another contract?
Yes. SPE2DB25FHR42 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHR42 competed?
The extent of competition for SPE2DB25FHR42 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award